ReviewComputational and structural biotechnology journal2026
An Overview on T-Cell Engagers: The Current Position in Both the Biological and Mathematical Context.
Review in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
T-cell engagers (TCEs) are immunotherapeutic drugs that are gaining interest and momentum in oncology, and since 2022, they have been increasingly approved for clinical use. However, there are still many issues and unknowns relating to their pharmacokinetics, efficacy, and adverse side effects. Mathematical models are in the perfect position to improve understanding of these key issues, expand on, and optimize currently approved TCEs. This paper will review the relevant biology behind TCEs, such as the mechanisms behind the antitumor response, the molecular biology of TCE construction, and their use in clinical settings. Then, the review will move to discuss TCE mathematical modeling, key methods, and conclusions to date.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.